ArticleBreast cancer research and treatment2022

Treatment of HR+/HER2- breast cancer in urban mainland China: results from the CancerMPact Survey 2019.

Bhavna Murali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.